Genentech Case 07/23/2008
Genentech Case 07/23/2008: UPDATE
According to a press release Genentech won Judge Leo Strine Jr. 's approval to settle a lawsuit in Delaware Chancery Court contending the stock was undervalued in the deal. Shareholders, including three pension funds, resolved the lawsuit after the companies agreed to an enhanced price of $95 a share and released more information about the bidding, according to court papers.
Only just 48 hours after the Swiss pharmacy corporation Roche (SWX: ROG.VX RO.S OTCQX RHHBY) announced its plan to acquire all outstanding shares of Genentech (NYSE:DNA), which they do not own already, a Southern California reputable law firm, which is specialized in security law, has filed a lawsuit for a shareholder against Swiss drug-maker Roche over its takeover attempt. The lawsuit was filed today, July 23rd, 2008 in Superior Court of the State of California in the County of San Mateo. The complaint accuses that the company’s Board of Directors, Roche Holdings, Inc. and Roche Holding Ltd. breached their fiduciary duty related to the offer by the world-leading health-care company Roche to acquire all the outstanding stock of Genentech not already owned by Roche for $89 per share in cash. According to the lawsuit the actions are substantially unfair to Genentech and its public shareholders and have caused and will contribute to cause significant damage to the company and its shareholders.